Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis.

MLA

Strusi, Gabriele, et al. “Phenethyl Isothiocyanate and Dasatinib Combination Synergistically Reduces Hepatocellular Carcinoma Growth via Cell Cycle Arrest and Oxeiptosis.” Frontiers in Pharmacology, Oct. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fphar.2023.1264032.

APA

Strusi, G., Suelzu, C. M., Horwood, N., Münsterberg, A. E., & Yongping Bao. (2023). Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis. Frontiers in Pharmacology, 1–13. https://doi.org/10.3389/fphar.2023.1264032

Chicago

Strusi, Gabriele, Caterina M. Suelzu, Nicole Horwood, Andrea E. Münsterberg, and Yongping Bao. 2023. “Phenethyl Isothiocyanate and Dasatinib Combination Synergistically Reduces Hepatocellular Carcinoma Growth via Cell Cycle Arrest and Oxeiptosis.” Frontiers in Pharmacology, October, 1–13. doi:10.3389/fphar.2023.1264032.